J
Jeffrey P. Callen
Researcher at University of Louisville
Publications - 386
Citations - 14952
Jeffrey P. Callen is an academic researcher from University of Louisville. The author has contributed to research in topics: Lupus erythematosus & Dermatomyositis. The author has an hindex of 58, co-authored 380 publications receiving 13576 citations.
Papers
More filters
Journal ArticleDOI
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri,Ana Maria Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,Paul R. Fortin,Ian N. Bruce,David A. Isenberg,Daniel J. Wallace,Ola Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,Sang Cheol Bae,John G. Hanly,Jorge Sanchez-Guerrero,Ann E. Clarke,Cynthia Aranow,Susan Manzi,Murray B. Urowitz,Dafna D. Gladman,Kenneth C. Kalunian,Melissa Costner,Victoria P. Werth,Asad Zoma,Sasha Bernatsky,Guillermo Ruiz-Irastorza,Munther A. Khamashta,Søren Jacobsen,Jill P. Buyon,Peter J. Maddison,Mary Anne Dooley,Ronald F van Vollenhoven,Ellen M. Ginzler,Thomas Stoll,Christine A. Peschken,Joseph L. Jorizzo,Jeffrey P. Callen,S. Sam Lim,Barri J. Fessler,Murat Inanc,Diane L. Kamen,Anisur Rahman,Kristjan Steinsson,Andrew G. Franks,Lisa Sigler,Suhail Hameed,Hong Fang,Ngoc Minh Pham,Robin L. Brey,Michael H. Weisman,Gerald McGwin,Laurence S. Magder +51 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE.
Journal ArticleDOI
A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck.
Elise A. Olsen,M. Lisa Abernethy,Carol L. Kulp-Shorten,Jeffrey P. Callen,Scott Glazer,Arthur C. Huntley,Michael K. McCray,Alicia Bucko Monroe,Eduardo Tschen,John E. Wolf +9 more
TL;DR: Topical masoprocol appears to be useful in the treatment of actinic keratoses andIrritation, as manifested by erythema or flaking, occurred in 61.5% of topical masop rocol-treated patients versus 26.7% of those treated with vehicle and did not correlate with clinical response.
Journal ArticleDOI
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
David A. Isenberg,Elizabeth Allen,Vernon T. Farewell,M. Ehrenstein,Michael G. Hanna,I.E. Lundberg,C. Oddis,Clarissa Pilkington,P. H. Plotz,D. L. Scott,Jiri Vencovsky,Rachel Cooper,Lisa G. Rider,Frederick W. Miller,Elizabeth Adams,Helene Alexanderson,Nancy Armentrout,Zohar Argov,Richard J. Barohn,Suzanne L. Bowyer,Hermine I. Brunner,Rubén Burgos-Vargas,Jeffrey P. Callen,Gail Cawkwell,Patrick Cherin,Yuen-Li Chung,Hanna Chwalińska-Sadowska,Robert D. Cooper,Cronin Me,Katarina Danko,Joyce Davidson,Peter B. Dent,Elizabeth M. Dugan,Brian M. Feldman,Richard Finkel,Ignacio García-De La Torre,Ekkehard Genth,Edward H. Giannini,Gerald J D Hengstman,Jeanne E. Hicks,Adam M. Huber,Hans Iko Huppertz,Lisa Imundo,Kent J. Johnson,Joseph L. Jorizzo,Lawrence Kagen,John T. Kissel,Marisa S. Klein-Gitelman,Abraham Garcia Kutzbach,Bianca Lang,Marissa Lassere,Carol B. Lindsley,Daniel J. Lovell,Sue Maillard,Peter N. Malleson,Alberto Martini,Thomas A. Medsger,Kevin J. Murray,Chester V. Oddis,Lauren M. Pachman,Amy Paller,Maria D. Perez,Paul H. Plotz,Dieter Pongratz,Angelo Ravelli,Ann M. Reed,Robert M. Rennebohm,Nicolino Ruperto,Seward Rutkove,Clyde Ryder,Jean Luc Senécal,Georges Serratrice,Jacques Serratrice,David Sherry,Kumaraswamy Sivakumar,Yeong Song,Richard D. Sontheimer,Ira N. Targoff,Maria L. Turner,Basiel van Engelen,Maria L. Villalba,Kelly Vincent,Victoria P. Werth,Patience H. White,James Witter,Robert Wortmann,Steven R. Ytterberg +86 more
TL;DR: The MITAX, MYOACT and MDI tools, which are now undergoing validity testing, should enhance the consistency, comprehensiveness and reliability of disease activity and damage assessment in patients with myositis.
Journal ArticleDOI
Chronic Cutaneous Lupus Erythematosus: Clinical, Laboratory, Therapeutic, and Prognostic Examination of 62 Patients
TL;DR: An analysis of therapeutic results in this series confirmed the beneficial effects of intralesional corticosteroids and antimalarial agents and demonstrated relatively poor responsiveness to topical or oral cortICosteroids.
Journal ArticleDOI
Pyoderma gangrenosum: an update.
TL;DR: The diagnosis of PG is one of exclusion and the management of this disorder begins with treatment of any underlying disease and local or systemic glucocorticoids or immunomodulating therapies.